期刊文献+

补肾活血方联合厄贝沙坦对早期糖尿病肾病患者尿微量白蛋白的影响 被引量:2

下载PDF
导出
摘要 目的:以补肾活血方联合厄贝沙坦治疗早期糖尿病肾病,探讨其对早期糖尿病肾病患者尿微量白蛋白的影响。方法:观察68例早期糖尿病肾病患者,随机分为治疗组36例和对照组32例,对照组予厄贝沙坦治疗,治疗组同时加用补肾活血汤为主的中药联合治疗,疗程8周,观察治疗前后的尿微量白蛋白的水平。结果:治疗后两组尿微量白蛋白与治疗前均降低,治疗组优于对照组。结论:补肾活血方联合厄贝沙坦治疗早期糖尿病肾病,比单独使用厄贝沙坦疗效提高,并具有较好的安全性。
作者 赖延青 卢蓁
出处 《赣南医学院学报》 2010年第4期594-595,共2页 JOURNAL OF GANNAN MEDICAL UNIVERSITY
  • 相关文献

参考文献7

二级参考文献14

  • 1李光伟,Step.,L.检测人群胰岛素敏感性的一项新指数[J].中华内科杂志,1993,32(10):656-660. 被引量:2126
  • 2Parving HH. Initiation and progression of diabetic nephropathy. N Engl J Med, 1996,335 : 1682-1683.
  • 3Gareia-Donaire JA, Segura J, Ruilope LM. An update of irbesartan and renin-anglotensin system blockade in diabetic nephropahy. Expert Opin Pharmacother, 2005,6 : 1587-1596.
  • 4Sasso FC, Carbonara O, Persico M, et al. Irbesartan reduces the albumin excretion rate in microalbuminuric type 2 diabetic patients independently of hypertension. Diabetes Care, 2002,25 : 1909-1913.
  • 5Rossing K, Schjoedt K J, Jensen BR, et al. Enhanced renoprotective effects of ultrahigh doses of irbesartan in patients with type 2 diabetes and microalbuminuria. Kidney Int, 2005,68 : 1190-1198.
  • 6Parving HH, Lehnert H, Brochner-Mortensen J, et al. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med, 2001,345,870-878.
  • 7Mathiesen ER, Hommel E, Hansen HP, et al. Randomised controlled trial of long term efficacy of captopril on preservation of kidney function in normotensive patients with insulin dependent diabetes and microalbuminuria. BMJ, 1999,319:24-25.
  • 8Heart Outcomes Prevention Evaluation (HOPE) Study Investigators. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICROHOPE substudy. Lancet, 2000,355:253-259.
  • 9The ACE Inhibitors in Diabetic Nephropathy Trialist Group. Should all patients with type 1 diabetes mellitus and microalbuminuria receive angiotensin-converting enzyme inhibitors? Ann Intern Med, 2001,134 : 370.
  • 10Lewis EJ, Hunsicker LG, Clarke WR, et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med, 2001,345:851- 860.

共引文献104

同被引文献50

引证文献2

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部